Cubic Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Cubic Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$2.48M	Buy	45,710 +1,055	+2%	+$53.7K	0.59%	50
2023 Q4	$2.29M	Sell	44,655 -950	-2%	-$49.9K	0.59%	53
2023 Q3	$2.65M	Sell	45,605 -4,317	-9%	-$265K	0.73%	42
2023 Q2	$3.19M	Buy	49,922 +290	+0.6%	+$19.4K	0.86%	36
2023 Q1	$3.44M	Sell	49,632 -430	-0.9%	-$30.3K	0.96%	32
2022 Q4	$3.6M	Sell	50,062 -2,850	-5%	-$215K	1.03%	27
2022 Q3	$3.76M	Sell	52,912 -150	-0.3%	-$10.9K	1.12%	26
2022 Q2	$4.09M	Sell	53,062 -905	-2%	-$68.9K	1.1%	25
2022 Q1	$3.94M	Hold	53,967	–	–	0.92%	36
2021 Q4	$3.37M	Sell	53,967 -800	-1%	-$46.9K	0.76%	42
2021 Q3	$3.24M	Sell	54,767 -240	-0.4%	-$15.8K	0.8%	43
2021 Q2	$3.68M	Buy	55,007 +1,025	+2%	+$66.8K	0.91%	39
2021 Q1	$3.41M	Sell	53,982 -30	-0.1%	-$1.87K	0.9%	41
2020 Q4	$3.35M	Buy	54,012 +1,500	+3%	+$92.2K	0.99%	36
2020 Q3	$3.17M	Buy	52,512 +3,000	+6%	+$181K	1.14%	32
2020 Q2	$2.91M	Buy	49,512 +1,245	+3%	+$74.5K	1.04%	36
2020 Q1	$2.69M	Buy	48,267 +3,422	+8%	+$209K	1.09%	36
2019 Q4	$2.88M	Buy	44,845 +2,635	+6%	+$151K	0.81%	45
2019 Q3	$2.14M	Buy	42,210 +5,280	+14%	+$248K	0.64%	50
2019 Q2	$1.68M	Buy	36,930 +1,982	+6%	+$92.3K	0.5%	59
2019 Q1	$1.67M	Sell	34,948 -177	-0.5%	-$8.82K	0.49%	61
2018 Q4	$1.83M	Sell	35,125 -50	-0.1%	-$2.69K	0.6%	56
2018 Q3	$2.18M	Sell	35,175 -700	-2%	-$41.5K	0.6%	56
2018 Q2	$1.99M	Sell	35,875 -2,149	-6%	-$116K	0.57%	58
2018 Q1	$2.4M	Buy	38,024 +25	+0.1%	+$1.61K	0.68%	50
2017 Q4	$2.33M	Sell	37,999 -750	-2%	-$46.9K	0.65%	53
2017 Q3	$2.47M	Sell	38,749 -150	-0.4%	-$8.76K	0.7%	52
2017 Q2	$2.17M	Buy	38,899 +1,050	+3%	+$57.1K	0.63%	54
2017 Q1	$2.06M	Sell	37,849 -300	-0.8%	-$16.5K	0.63%	51
2016 Q4	$2.23M	Buy	38,149 +2,000	+6%	+$109K	0.69%	49
2016 Q3	$1.95M	Buy	36,149 +1,205	+3%	+$77.4K	0.63%	58
2016 Q2	$2.57M	Sell	34,944 -660	-2%	-$46.6K	0.87%	42
2016 Q1	$2.27M	Sell	35,604 -115	-0.3%	-$7.25K	0.76%	50
2015 Q4	$2.46M	Sell	35,719 -15	-0%	-$991	0.85%	46
2015 Q3	$2.12M	Sell	35,734 -500	-1%	-$31.7K	0.75%	54
2015 Q2	$2.41M	Sell	36,234 -600	-2%	-$39.5K	0.77%	53
2015 Q1	$2.38M	Sell	36,834 -4,325	-11%	-$271K	0.76%	52
2014 Q4	$2.43M	Sell	41,159 -550	-1%	-$31K	0.78%	46
2014 Q3	$2.13M	Sell	41,709 -1,400	-3%	-$69.9K	0.75%	52
2014 Q2	$2.09M	Sell	43,109 -512	-1%	-$25.2K	0.69%	59
2014 Q1	$2.27M	Sell	43,621 -200	-0.5%	-$10.6K	0.78%	51
2013 Q4	$2.33M	Sell	43,821 -875	-2%	-$44.6K	0.73%	57
2013 Q3	$2.07M	Sell	44,696 -200	-0.4%	-$8.78K	0.67%	59
2013 Q2	$2.01M	Buy	+44,896	New	+$1.95M	0.69%	58

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cubic Asset Management's BMY Position: Q1 2024 in Review

Cubic Asset Management increased its Bristol-Myers Squibb (BMY) stake by 2.4% in Q1 2024, buying an estimated $53.7K and bringing the position to 45,710 shares worth $2.48M. The position accounts for 0.59% of the portfolio, ranked #50.

Cubic Asset Management first reported a position in BMY in Q2 2013 and has held it in 44 quarters since. The position peaked at $4.09M in Q2 2022. 2,331 funds tracked by Wall St. Rank hold BMY as of Q1 2024.

Cubic Asset Management held 45,710 shares of Bristol-Myers Squibb worth $2.48M as of Q1 2024.
Cubic Asset Management bought 1,055 Bristol-Myers Squibb shares in Q1 2024, an estimated $53.7K.
Bristol-Myers Squibb made up 0.59% of Cubic Asset Management's portfolio in Q1 2024, its #50 holding.
Cubic Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 44 quarters since.
Cubic Asset Management's Bristol-Myers Squibb position peaked at $4.09M in Q2 2022.
2,331 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.

Based on Cubic Asset Management's 13F filing for Q1 2024, filed 24 Apr 2024.